Systematic Review of Humanistic and Economic Burden of Symptomatic Chronic Obstructive Pulmonary Disease.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 5, p. 467, doi. 10.1007/s40273-015-0252-4
- By:
- Publication type:
- Article
Works matching IS 11707690 AND DT 2015 AND VI 33 AND IP 5
Results: 10
1
2
Economic Evaluations with Agent-Based Modelling: An Introduction.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 5, p. 423, doi. 10.1007/s40273-015-0254-2
- By:
- Publication type:
- Article
3
Exploring Structural Uncertainty in Model-Based Economic Evaluations.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 5, p. 435, doi. 10.1007/s40273-015-0256-0
- By:
- Publication type:
- Article
4
The Clinical and Cost Effectiveness of Aflibercept in Combination with Irinotecan and Fluorouracil-Based Therapy (FOLFIRI) for the Treatment of Metastatic Colorectal Cancer Which has Progressed Following Prior Oxaliplatin-Based Chemotherapy: a Critique of the Evidence
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 5, p. 457, doi. 10.1007/s40273-015-0257-z
- By:
- Publication type:
- Article
5
Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information is Needed?
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 5, p. 489, doi. 10.1007/s40273-015-0259-x
- By:
- Publication type:
- Article
6
Cost of Acute Stroke Care for Patients with Atrial Fibrillation Compared with Those in Sinus Rhythm.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 5, p. 511, doi. 10.1007/s40273-015-0263-1
- By:
- Publication type:
- Article
7
Adapting the CHEERS Statement for Reporting Cost-Benefit Analysis.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 5, p. 533, doi. 10.1007/s40273-015-0265-z
- By:
- Publication type:
- Article
8
Cost-Utility Analysis of Intravenous Immunoglobulin for the Treatment of Steroid-Refractory Dermatomyositis in Thailand.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 5, p. 521, doi. 10.1007/s40273-015-0269-8
- By:
- Publication type:
- Article
9
Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 5, p. 535, doi. 10.1007/s40273-015-0277-8
- By:
- Publication type:
- Article
10
A Review and Classification of Approaches for Dealing with Uncertainty in Multi-Criteria Decision Analysis for Healthcare Decisions.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 5, p. 445, doi. 10.1007/s40273-014-0251-x
- By:
- Publication type:
- Article